The present invention relates to a method for the diagnosis or the prognosis of metastasis in lung cancer which comprises determining if the c-MAF gene is amplified in a primary tumor sample. Likewise, the invention also relates to a method for the diagnosis or the prognosis of metastasis in lung cancer, as well as to a method for determining the tendency to develop bone metastasis with respect to metastasis in other organs, which comprise determining the c-MAF gene expression level. Finally, the invention relates to the use of a c-MAF inhibitor as therapeutic target for treating the lung cancer.
本发明涉及肺癌转移的诊断或预后方法,该方法包括确定原发肿瘤样本中 c-MAF
基因是否扩增。同样,本发明还涉及一种诊断或预后肺癌转移的方法,以及一种确定相对于其他器官转移的骨转移倾向的方法,该方法包括确定 c-MAF
基因的表达
水平。最后,本发明涉及使用 c-MAF
抑制剂作为治疗肺癌的靶点。